reported that XIST is highly expressed in CRC tissues and cells, and its downregulation in vitro inhibits CRC cell proliferation, which is regulated through the XIST/miR-448/GRHL2 axis (204), Li et al. This evidence concerns the gene GRHL2 and colorectal carcinoma.